Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chronic Endometritis and Recurrent Miscarriage (CERM trial)
2019-000585-38Phase 2Unknown
- Sponsor
- University Hospitals Coventry and Warwickshire NHS Trust
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of doxycycline in endometritis and recurrent miscarriage (RPL), sponsored by University Hospitals Coventry and Warwickshire NHS Trust. Primary endpoints: Primary outcome measures and Improvement of chronic endometritis. Status: unknown.
02
Drugs
doxycycline
03
Conditions
endometritisrecurrent miscarriage (RPL)
Beyond the preview
Go deeper on 2019-000585-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-000585-38.